Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) EBT Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed EBT Margin for 17 consecutive years, with 1.85% as the latest value for Q1 2026.

  • Quarterly EBT Margin fell 304.0% to 1.85% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 4.49% through Jan 2026, down 445.0% year-over-year, with the annual reading at 4.49% for FY2026, 445.0% down from the prior year.
  • EBT Margin for Q1 2026 was 1.85% at Usana Health Sciences, up from 0.84% in the prior quarter.
  • The five-year high for EBT Margin was 13.03% in Q1 2022, with the low at 0.84% in Q3 2025.
  • Average EBT Margin over 5 years is 9.04%, with a median of 9.95% recorded in 2022.
  • The sharpest move saw EBT Margin soared 203bps in 2023, then plummeted -845bps in 2025.
  • Over 5 years, EBT Margin stood at 10.0% in 2022, then grew by 20bps to 12.04% in 2023, then crashed by -59bps to 4.88% in 2024, then plummeted by -83bps to 0.84% in 2025, then soared by 120bps to 1.85% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 1.85%, 0.84%, and 7.98% for Q1 2026, Q3 2025, and Q2 2025 respectively.